Drug research

DT120

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

Also recorded as LSD D-Tartrate; MM120; lysergide tartrate

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)NCT07592689	Definium Therapeutics US, Inc.	Phase 3	Recruiting	2027-09Estimated
A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage)NCT06741228	Definium Therapeutics US, Inc.	Phase 3	Active not recruiting	2026-07-15Actual
A Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge)NCT06941844	Definium Therapeutics US, Inc.	Phase 3	Active not recruiting	2026-05-20Actual
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)NCT06809595	Definium Therapeutics US, Inc.	Phase 3	Active not recruiting	2026-08-13Actual

Definium Therapeutics US, Inc.RecruitingPrimary completion: 2027-09 · Estimated

Trial details

Definium Therapeutics US, Inc.Active not recruitingPrimary completion: 2026-07-15 · Actual

Trial details

Definium Therapeutics US, Inc.Active not recruitingPrimary completion: 2026-05-20 · Actual

Trial details

Definium Therapeutics US, Inc.Active not recruitingPrimary completion: 2026-08-13 · Actual

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.